Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age3-9
SponsorRoswell Park Cancer Institute
About this trial
The current study will assess the acceptability and feasibility of the CareMeds intervention with a larger sample (N = 100) across multiple sites in Buffalo, NY, and Atlanta, GA.
Eligibility criteria
Qualifiers
Parent of a child who is diagnosed and being treated for any type of acute lymphoblastic leukemia (ALL) at a study site.
Parent has primary medication responsibility.
Pediatric patient aged 3-9 years
Child on therapy that includes home-based oral anti-cancer medication, such as 6-MP.
Disqualifiers
Parent is unwilling or unable to follow protocol requirements
Trial design
Treatments tested in this trial
- CareMeds Intervention
- Usual Care Group
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Roswell Park Cancer Institute
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov